Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M. +30 more·2017·Movement Disorders
DOI 10.1002/mds.27115

Cited by (736)

Items 601–700 of 736

  1. Artificial Intelligence in the Diagnosis of Parkinson's Disease
    Sree Mahalakshmi Pasumarthy, Deepika Katam, Keerthika Neella, Sowmya Gayathri Mylavarapu · 2024 · Journal of Pharma Insights and Research
  2. Implications for the role of natural products in Parkinson disease therapy
    A. Batawi · 2024 · Archives of medical science : AMS
  3. An exploratory study on the ability of manganese to supplement rotenone neurotoxicity in rats.
    María Teresa Ibarra-Gutiérrez, Norma Serrano-García, M. Alcaraz-Zubeldia, José Pedraza-Chaverrí, M. Orozco-Ibarra · 2024 · Brain Research
  4. Non-transgenic models of Parkinson's disease: The pursuit of a resemblance
    Letícia Germino Veras, Henrique de Oliveira Amaral, Isabela Ferreira Lima Mota, Caio Vinícius Ibias Belardinelli de Azevedo, Yasmin Costa e Carrilho, Márcia Renata Mortari, Bruna Lotufo Denucci · 2024 · Brain Disorders
  5. Clinical Scores Prediction and Medication Adjustment for Course of Parkinson's Disease
    Han Chen, Wenxuan Wu, Xiaofen Xing, Xiangmin Xu · 2024 · IEEE International Conference on Acoustics Speech and Signal Processing
  6. GiOPARK Project: The Genetic Study of Parkinson’s Disease in the Croatian Population
    V. Rački, G. Bergant, Eliša Papić, Anja Kovanda, M. Hero, G. Rožmarić, N. Starčević Čizmarević, S. Ristić, S. Ostojić, M. Kapović et al. · 2024 · Genes
  7. Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients
    Josevânia Fulgêncio de Lima Arruda, L. D. Silva, R. T. Brisson, Gabriel de Castro Micheli, Marco Antônio Sales Dantas de Lima, A. L. D. de Rosso, Rita de Cássia Leite Fernandes · 2024 · Arquivos de Neuro-Psiquiatria
  8. Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease
    Bianca Vlcek, Sylvie Dumas, Sara Ekmark‐Lewén, Eleonora Rubino, Martin Ingelsson, Åsa Wallén‐Mackenzie · 2023 · Exploration of Neuroprotective Therapy
  9. LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration
    Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi, Nicole Schneiderhan‐Marra et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  10. An End-to-End Deep Learning Approach for Diagnosis of Parkinson’s Disease Based on Hand Drawing
    Yifan Wang, Yifan Zhang · 2021 · Journal of Physics: Conference Series
  11. Estimulación cerebral profunda para la enfermedad de Parkinson: criterios de selección, abordaje quirúrgico, efectos secundarios y controversias.
    Roberto Leal Ortega · 2021
  12. Molecular Imaging of Neurodegenerative Parkinsonism.
    K. Frey, N. Bohnen · 2021 · PET Clinics
  13. Epidemiology of Parkinson's disease
    Tereza Bartoníková, Kateřina Menšíková, Vladimí­r Janout, Petr Kaňovský · 2020 · Neurologie pro praxi
  14. Modeling the pathophysiology of Parkinson’s disease in patient-specific neurons
    Jian Feng · 2020 · Experimental Biology and Medicine
  15. Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine
    Véronique Sgambato · 2020 · Progress in brain research
  16. Human embryonic stem cells-derived dopaminergic neurons transplanted in parkinsonian monkeys recover dopamine levels and motor behavior
    Adolfo López-Ornelas, Itzel Escobedo-Ávila, Gabriel Ramirez‐Garcia, Rolando Lara-Rodarte, César Meléndez-Ramírez, Beetsi Urrieta-Chávez, Tonatiuh Barrios‐García, Verónica Alejandra Cáceres-Chávez, Xóchitl Flores-Ponce, Francia Carmona et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  17. The migration of multipotent mesenchymal stromal cells after systemic and local administration in an experimental model of Parkinson’s disease
    M. Zafranskaya, Д. Б. Нижегородова, Natalia E. Aleynikova, T. Kuznetsova, Margarita I. Vanslav, T. В. Ignatovich, A. V. Boiko, V. Ponomarev · 2019 · Annals of Clinical and Experimental Neurology
  18. Brasilia Parkinson Cohort: assessing clinical, neuropsychological and imaging predictors of cognitive decline in Parkinson's disease
    Pedro Renato de Paula Brandão, F. Maluf, T. Grippe, Ingrid Faber, Danilo Assis Pereira, N. Allam, F. Cardoso, C. Tomaz, M. Tavares · 2019
  19. Sudden Unexpected Death in Parkinson's Disease (SUDPAR): a fatal event that James Parkinson did not address.
    F. Scorza, A. Fiorini, C. Scorza, J. Finsterer · 2018 · Age and Ageing
  20. At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
    Daniel A. Weintraub, Jamie L. Hamilton, Jamie L. Eberling, Irene Litvan · 2018 · Movement Disorders
  21. Can plasma cholinesterase act as an adjuvant prognostic index in acute burn cases?
    Yasmine Fikry, A. Elsayed, M. Sayed, Dalia M. Nabil · 2021
  22. Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  23. fMRI in Parkinson’s Disease
    Hartwig Roman Siebner, Damian Marc Herz · 2013 · Springer eBooks
  24. Non-motor Symptoms in Parkinson’s Disease
    Vladimira Vuletić · 2020 · Springer eBooks
  25. Clinical Trials for Orthostatic Hypotension in Parkinson’s Disease and Other Synucleinopathies
    Jose‐Alberto Palma, Horacio Kaufmann · 2020 · Neuromethods
  26. Olive leaf-derived exosome-like vesicles attenuate neurotoxicity in an in vitro rotenone model of Parkinson’s disease
    Aya Sahsahi, Nurdan Sena Değirmenci, Mehtap Aydın, Fikrettin Şahi̇n, Sevim Işık · 2026 · Metabolic Brain Disease
  27. Frontal aperiodic activity and sensorimotor theta clustering are differentially modulated by tDCS during proprioceptive training in Parkinson’s disease: An EEG study
    Hasti Heydarpour, Mohammed N. Ashtiani, Farid Bahrpeyma, Abbas Tafakhori · 2026 · Neuroscience
  28. Parkinson's Disease Detection Using Empirical Fourier Decomposition of Speech Signal.
    S. S. Nayak, Anand D. Darji, Prashant K. Shah, J. Orozco-Arroyave · 2026 · Journal of Voice
  29. Rab proteins as diagnostic biomarkers for Parkinson’s disease: a systematic review
    A. Ravinther, H. Dewadas, Rui-Jia Hou, Nicole Tze Er Lee, Cheng-Ting Chien, C. Foo, Y. Lim · 2026 · Advanced Pharmaceutical Bulletin
  30. Health economics of Parkinson's disease prevention: why early detection matters in low- and middle-income countries.
    R. D. Jamora, Mykha Marie B. Tabuzo-Acuin, Norlinah Mohamed Ibrahim, Yoshio Tsuboi · 2026 · Journal of neural transmission
  31. Dance as Rehabilitation in Parkinson’s Disease: A Scoping Review of Motor, Non-Motor, and Cognitive Outcomes
    Simran Rooprai, Nicholas Daniel Ramcharran, Caitlin van den Hoorn, Jenna Smith‐Turchyn, Nicole D. Anderson, Joseph F. X. DeSouza · 2026 · Journal of Dance Medicine & Science
  32. The Therapeutic Potential of Purmorphamine Across Disease Models
    Ashis Dhar, Ahnaf Dil Sharar, Saikarthik Papisetty, Mohamad Bydon, F. M. Moinuddin · 2026 · Journal of Cellular and Molecular Medicine
  33. Multiple Mechanisms of Dopamine Modulation of Neuronal Excitability and Neurotransmission in the Striatum: A Personal and Historical Perspective
    Carlos Cepeda · 2026 · Cells
  34. Global research synergy: Advancing fundamental Parkinson's research through international collaboration
    Jesus Daniel Gutierrez-Arratia, Paula Saffie Awad, Artur Francisco Schumacher Schuh, Mario Cornejo‐Olivas · 2026 · Journal of Parkinson s Disease
  35. Network state transitions under deep brain stimulation: A Wilson–Cowan model of Parkinson’s Disease
    A. Singh, Phool Singh · 2026 · Journal of Computational Neuroscience
  36. Blood-brain barrier penetration and tissue distribution of the selective membrane progesterone receptor α (mPRα/PAQR7) agonist Org OD 02-0
    László Ákos Kovács, János Schmidt, Abolfazl Golgol, Zsolt Pirger, Istvan Fodor · 2026 · Frontiers in Endocrinology
  37. Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets
    Diana Denisse Álvarez‐Luquín, Rubén Roberto González-Fernández, Eduardo Ichikawa-Escamilla, Martin Eduardo Torres-Velasco, Eduardo José Martínez-Martínez, Asiel Arce-Sillas, Víctor Hugo Juárez-Vaquera, Clara Leticia Miranda-Narváez, Marisela Hernández, Laura Virginia Adalid-Peralta · 2026 · Experimental Neurology
  38. Multi-delay arterial spin labelling-based metabolic connectomes reveals topological alterations in Parkinson's disease.
    Madhu Thakur, Shao-Hua Ding, Xiang Lu, Bei-Lei Chen, Qi Yan, Da-Ming Shen, Hong-Ying Zhang, Song-An Shang, Xin Zhou · 2026 · Magnetic Resonance Imaging
  39. How (We Think) Parkinson's disease begins
    Tiago F. Outeiro, Eduard S. Tolosa · 2026 · Parkinsonism & Related Disorders
  40. Genetic context unmasks olfactory loss as a marker for dyskinesia risk via levodopa exposure trajectories in Parkinson's disease.
    Zhiying Zhang, Mei-Qi Zhan, Jiangpei Zhao, Yuzhou Wang · 2026 · Parkinsonism & Related Disorders
  41. Crosstalk between α-synuclein accumulation, NLRP3 inflammasome activation, oxidative stress, and apoptosis in a rotenone-induced Parkinson rat model.
    Homa Vali Pour, M. Alfateh, Sanaz Mirzayan Shanjani, Maryam Tajeri, Saeid Abbasi-Maleki · 2026 · Biochemical and Biophysical Research Communications - BBRC
  42. The aging brain that doesn’t fail: how neural resilience masks neurodegeneration
    Andrew Eisen, Heather D. Durham, Erik Pioro · 2026 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  43. Association of the miR-146a rs57095329 polymorphism with susceptibility and clinical phenotypes in Parkinson’s disease
    Guangxi Chen, Ya-Wen Zhang, Tao Wang · 2026 · Neurogenetics
  44. Follow-up and outcome of patients with primary BH4 deficiencies
    F. Nardecchia, F. Manti, Agnese De Giorgi, S. Galosi, Jennifer Friedman, V. Leuzzi · 2026 · Frontiers in Neurology
  45. Clinical significance of a novel inflammatory-nutritional index in Parkinson’s disease severity evaluation
    Wenbo Xiu, G N Zhang, Yang Chen, Chaonan Sun, Yanping Gao, An Li, Haiping Zhang, Ping Shuai, Bolin Deng, Jing Cheng et al. · 2026 · European journal of medical research
  46. Frontal and temporal hyper-perfusion in Parkinson's disease with subjective cognitive decline
    Kiyoaki Takeda, Atsushi Shima, Akira Nishida, Daisuke Kambe, Koji Furukawa, Haruhi Sakamaki‐Tsukita, Kenji Yoshimura, Ikko Wada, Yusuke Sakato, Yuta Terada et al. · 2026 · Parkinsonism & Related Disorders
  47. Dental Caries Experience in Older Adults With Parkinson's Disease: A Systematic Review and Meta‐Analysis
    Victor Zanetti Drumond, Thais Alves de Oliveira, José Alcides Almeida de Arruda, Raissa Costa Leal Pavione, Najara Barbosa da Rocha, Ricardo Alves Mesquita, Lucas Guimarães Abreu · 2026 · Special Care in Dentistry
  48. Structural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies
    Phelippe do Carmo Gonçalves, Irina Fernández, Claudio O. Fernández · 2026 · Journal of Parkinson s Disease
  49. Recent Advances in Nanoscale Metal–Organic Frameworks as Nanozymes and Drug Carriers for Inflammatory Disease Therapy
    Peilin Niu, Yanting Ji, S Liu, Tiantian Zhang, Qichao Tan, Yidong Wang, Kai Dong, Jianfeng Xing · 2026 · ACS Applied Nano Materials
  50. Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson’s disease
    Sai Li, Ruiting Chen, Qing Li, Yicheng Hsu, Jia-Qi He, Yihang Su, Dong-Cui Wang, Hao Zhou, Wei-Wei Zhang, L. Meng et al. · 2026 · npj Parkinson's Disease
  51. Domain-driven verbal and non-verbal dissociations in cognition and social cognition in Parkinson’s disease
    Sara Bottiroli, Martina Cangelosi, S. Lecce, S. Bernini, Micol Avenali, C. Tassorelli, T. Vecchi, Elena Cavallini · 2026 · Frontiers in Psychology
  52. Multisystem regulation of reward and addiction: beyond the dopaminergic system
    Óscar Arias-Carrión, Emmanuel Ortega‐Robles, Mario Treviño, Magdalena Guerra‐Crespo, Elı́as Manjarrez, Ernst Pöppel · 2026 · Frontiers in Pharmacology
  53. Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease
    Yang Li, Lijun Guo, Xiya Yu, Changgeng Peng · 2026 · Ageing and Neurodegenerative Diseases
  54. Hippocampal atrophy in untreated de novo Parkinson’s disease with obstructive sleep apnea
    Kristína Burdová, F. Růžička, Josef Mana, P. Filip, J. Nepožitek, S. Dostálová, P. Peřinová, O. Bezdicek, Petr Gregorovič, Filip Havlík et al. · 2026 · npj Parkinson's Disease
  55. LRRK2 regulates ArfGAP1 membrane localization, activity and neuronal integrity via phosphorylation within its lipid-sensing ALPS2 motif
    Md Shariful Islam, V. Cóppola-Segovia, A. Musso, Darren J. Moore · 2026 · Frontiers in Molecular Neuroscience
  56. From bench to bedside: The evolving role of focused ultrasound in managing Parkinson’s disease
    Xiao-Lan Xu, Qun Xu, An-Yu Tao, You-Bin Deng, Peng-Xuan Zhao, Ya-Ni Liu · 2026 · Oncology and Translational Medicine
  57. Playlist for Parkinson’s: a novel way to engage in music research dissemination
    D. Rose, Rafael Jerjen, F. Stuart, Valérie J. Halter, P. Paolantonio, Sabrina Köchli, Olivier Senn, Ellen Poliakoff, Michelle Phillips · 2026 · Research for All
  58. Vps35 p.D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammation
    Isaac Bul Deng, Mengfei Bu, Jordan Follett, Robert C. Sharp, Adamantios Mamais, Leyna Xoi, Fahong Yu, Georges Rabil, Shannon C. Wall, Matthew James Farrer · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Meta-analysis reveals apolipoprotein ε4 confers higher susceptibility to Parkinson’s disease dementia in Asian populations
    Naseem Akhter, Ngoc Anh Ho, Ryan C. Nangreave, Saif Ahmad, Andrew F. Ducruet, Kanchan Bhatia · 2026 · Frontiers in Aging Neuroscience
  60. The relationship between herpesviruses and Parkinson’s disease: prevalence, viral load, and clinical implications
    Sare Madani, Kumars Amini, Seyed Amir Hassan Habibi, Mohammad Hassan Shahhosseiny, Taher Mohammadian · 2026 · Acta Virologica
  61. A regression analytical model of serum levodopa metabolic profile in Parkinson's disease
    Akiko Chukyo, Osamu Komori, Motoki Fujimaki, Naoko Kaga, Hikari Taka, Yuanzhe Li, Shin-Ichi Ueno, Haruka Takeshige‐Amano, Manabu Funayama, Tomohiro Ishimaru et al. · 2026 · Heliyon
  62. A Swap-Adversarial Framework for Improving Domain Generalization in Electroencephalography-Based Parkinson's Disease Prediction
    Seongwon Jin, Hanseul Choi, Sung-Gu Yang, Sung-Hong Park, Jibum Kim · 2026 · arXiv.org
  63. Speech Motor Deficits in Developmental Stuttering and Parkinson's Disease: From Cellular and Circuit to Network‐Level Disruptions
    Ariana Z. Turk, Marissa Millwater, Sufie Sheikh‐Bahaei, Fatemeh Mollaei, Markus Rießland, Shahriar SheikhBahaei · 2026 · European Journal of Neuroscience
  64. Cortical activation and functional connectivity between healthy elderly and Parkinson’s disease patients and between cognitive subgroups of Parkinson’s patients: a multichannel functional near-infrared spectroscopy study
    Xiaodie Liu, Shanshan Zhou, Wenyi Chen, Mengyuan Chen, Yawen Pan, Huabao Xie, Yinghao Zhi · 2026 · Frontiers in Aging Neuroscience
  65. On/Off-Discrepancies in medical decision-making: utilising the reversibility of deep brain stimulation to strengthen patient autonomy
    Lukas J. Meier, Aaron D’Sa · 2026 · Ethik in der Medizin
  66. Mapping motor cortex “hand knob” metrics to symptom hemidominance in Parkinson's disease: from width comparison to machine learning
    Friedrich Erhart, Konstantin Hölzl, A. Langer, Christof Brücke, Josa Maria Frischer, Prof Dr Gregor Kasprian, RÖSSLER Karl, Klaus Novak · 2026 · Brain and Spine
  67. Common features in the gut microbiota of underweight and overweight individuals and patients with Parkinson’s disease - a mini-review
    Emilia Kaczorowska, Aleksandra Tarasiuk, Karolina Joanna Ratajczyk, Karolina Wyka, Agata Gajos, Jakub Fichna · 2025 · Pharmacological Reports
  68. Preferred tempo influence on learning transfer from perceptual to stepping timing in Parkinson's disease.
    Itzamná Sánchez-Moncada, Gabriel Neri-Nani, Adrián Elías Jefté, Hugo Merchant · 2025 · Neuroscience
  69. Current aspects of the relationship between depression and cognitive impairment in patients with Parkinson’s disease
    Marina Romanovna Nodel · 2025 · S S Korsakov Journal of Neurology and Psychiatry
  70. Machine Learning Approaches to Influential ROI Selection in Parkinson’s Disease: A Comparative Analysis of LASSO, Recursive Feature Elimination, and Random Forest
    Keyvan Olazadeh, Nasrin Borumandnia, Hamid Alavi Majd · 2025 · Archives of Neuroscience
  71. Parkinson's disease and sleep: from biomarkers to clinical stratification
    Kimberly Boschi de Abreu Cavalli, F. Filippini, Pablo Cortadi · 2025 · International journal of neurology
  72. Sleep disorders in patients diagnosed with Parkinson's disease at a specialized medical center in Rosario (Santa Fe, Argentina), 2024
    Kimberly Boschi de Abreu Cavalli, Fernando Filippini, Pablo Cortadi · 2025 · International Journal of Neurology
  73. Evaluation of the therapeutic effect of adaptive deep brain stimulation on motor symptoms and sleep disturbances in Parkinson’s disease and construction of a response prediction model
    Mingming Su, Lihong Qu, Xin Wang, Bao Wang, Nan Li, Xue-Lian Wang, Zhaohui Zheng · 2025 · Frontiers in Neurology
  74. Variational Mode Decomposition Based Statistical and Entropy Features for Parkinson's Disease Detection from Speech Signal
    S. S. Nayak, Anand D. Darji, Prashant K. Shah · 2025 · 2025 7th International Conference on Information Systems and Computer Networks (ISCON)
  75. When Sex Overcomes Motor Phenotype: New Evidence on Cognitive and Neurobehavioral Symptoms in Parkinson's Disease
    Matteo Favaro, Chiara Longo, Donatella Ottaviani, Alessandra Dodich, Costanza Papagno · 2025 · Brain and Behavior
  76. The Role of Intermittent Fasting and Calorie Restriction in Preventing Neurodegenerative Diseases within the Context of Adult Neurogenesis
    Deniz Oruç, Sevim Işık · 2025 · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
  77. REVISITING PARKINSON’S DISEASE MANAGEMENT: A COMPREHENSIVE REVIEW OF HERBAL APPROACHES AND MODERN DELIVERY STRATEGIES
    Shivaraj Hooli, K. Sutar, Sankalp S. Sammasagi · 2025 · International Journal for Sciences and Technology
  78. Practical clinical measures highlight cognition-balance associations in Parkinson's disease
    Nicholas D. Burt, Karl Arabian, James Scott Parrott, Rosemary Gallagher · 2025 · Gait & Posture
  79. Generadores de pulso implantable recargables y no recargables para la estimulación cerebral profunda en pacientes con enfermedad de Parkinson
    Sergio Francisco Ramírez García, L. Morón-Duarte, Gabriel José Arango Uribe, C. L. Moreno López, Nancy Yomayusa González · 2025 · Acta neurológica colombiana
  80. Parkinson Hastalığında SİBO (İnce Bağırsak Bakteri Aşırı Çoğalması): WOS örneği ile Bibliyometrik İnceleme
    Selen İlhan · 2024 · Journal of Immunology and Clinical Microbiology
  81. Subsecond Analysis of Locomotor Activity in Parkinsonian Mice
    Daniil Berezhnoi, Hiba Douja Chehade, Gabriel Simms, Liqiang Chen, K. Narasimhan, S. Dravid, Hong-Yuan Chu · 2024 · eNeuro
  82. Viscous damping of tremor using a wearable robot with an optimized mechanical metamaterial
    Suhas Raghavendra Kulkarni, Dino Accoto, Domenico Campolo · 2024 · Wearable Technologies
  83. A novel function for α-synuclein as a regulator of NCK2 in olfactory bulb: implications for its role in olfaction
    Jing Ren, Chao Wu, Mengxia Zeng, Mingqin Qu, Ge Gao, Ning Chen, Jingjing Yue, Yuwen Jiang, Tongfei Zhao, Na Xiang et al. · 2024 · Cell & Bioscience
  84. Importance of health history analysis in Parkinson's disease
    Vinayak Majhi, Sudip Paul, Goutam Saha, A. Kunwar, Manob Saikia · 2024 · Heliyon
  85. Pathological cell assembly dynamics in a striatal MSN network model
    Astrid Correa, Adam P.D. Ponzi, Vladimir Calderón, Rosanna Migliore · 2024 · Frontiers in Computational Neuroscience
  86. A Group Analytic Model of Parkinson’s
    Susanne Vosmer, Marty Cooper, Tracy D. Morgan, Fanita Henderson, J. Mull · 2024 · Group
  87. Epigallokateşin Gallatın (EGCG) Parkinson Hastalığı Patogenezinde Potansiyel Koruyucu Etkileri
    Elif Yıldız, İlknur Gökçe Yıldırım · 2024 · Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi
  88. Chronic Cephalalgia-Parkinsonism Complex Revealing a Meningioma in a Young Patient: A Case Report
    Y. Zakaria, S. Benlamkadam, Hamidou Guillaume Turpin, Najib Kissani, M. Chraa · 2024 · Cureus
  89. Potential use of neuroprotective and L-DOPA-rich plants in parkinsonian therapy
    Jamal Mohammad Arif, Yusuf Jamal, Feras Almarshad, Abdulrahman Alshahrani, Mohammed Atef · 2023 · NeuroPharmac Journal
  90. Different associated factors of subjective cognitive complaints in patients with early and advanced Parkinson's disease
    Juan Huang, Lin Chen, Binbin Hu, Hui Wang, Xinyue Zhang, Xingfu Tian, Shu Wang, Wei Huang · 2023 · Frontiers in Aging Neuroscience
  91. Validity of the Vienna Visuo-Constructional Test 3.0-Screening, the Mini-Mental State Examination, and the Clock Drawing Test for Diagnosing Parkinson’s Disease
    Reiko Alice Fok, Sonja Zehetmayer, Christof Brücke, Johann P. Lehrner · 2023 · Zeitschrift für Neuropsychologie
  92. Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells
    V. Valadez-Barba, Karen J. Juárez-Navarro, Eduardo Padilla‐Camberos, Néstor Fabián Díaz, José Raúl Guerra-Mora, Nestor Emmanuel Diaz-Martinez · 2023 · Neurología (English Edition)
  93. Classification of Alzheimer??s Disease using combined features of fMRI Brain Network and clinical scales
    Xia Xu, Wen-Jie Wang, Zeng-Bei Yuan, Xinlin Li, Tao Wu, Xu-Feng Yao · 2023 · PCCNT
  94. Sexual health in women with Parkinson’s disease: Motor, non-motor, and social impacts
    Kátia Cirilo Costa Nóbrega, Isaíra Almeida Pereira da Silva Nascimento, Bruno Rafael Antunes Souza, Raíssa Amorim Gonçalves, Thalyta Silva Martins, Geovanna Ferreira Santos, Bruno Eron de Almeida da Silva, André Frazão Helene, Antônio C. Roque, Rodolfo Savica et al. · 2023 · medRxiv
  95. Study of physiological and pathological information mining with biological information similarity analysis
    Queena Chan, Shuyu Chen, Yutong Shen · 2023 · Theoretical and Natural Science
  96. Serum levels of p-tau181 in patients with Parkinson’s disease
    Zhanglin Tian, Long Bo, Mi Xiong, Yuhan Dong, Youdong Wei · 2023 · International Journal of Biology and Life Sciences
  97. Proteins and transcriptional dysregulation of the brain extracellular matrix in Parkinson’s disease: A systematic review
    Wote Amelo Rike, Shani Stern · 2023 · medRxiv
  98. Introduction to Diagnostic Challenges in Movement Disorders
    A. Mahajan, L. Shih · 2023 · Seminars in neurology
  99. Introduction to Diagnostic Challenges in Movement Disorders
    Abhimanyu Mahajan, Ludy C. Shih · 2023 · Seminars in neurology
  100. Environmental and genetic risk factors for Parkinson’s disease
    М. А. Никитина, Valentina Mikhailovna Alifirova, Elena Yu. Bragina, Н. П. Бабушкина, Densema E. Gomboeva, Maria S. Nazarenko · 2023 · Bulletin of Siberian Medicine